tiprankstipranks
Trending News
More News >
Wanjia Group Holdings Ltd. (HK:0401)
:0401
Hong Kong Market

Wanjia Group Holdings Ltd. (0401) AI Stock Analysis

Compare
0 Followers

Top Page

HK:0401

Wanjia Group Holdings Ltd.

(0401)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
HK$0.13
▲(45.56% Upside)
The score is primarily held back by weak financial performance (declining revenue and ongoing losses), with only moderate balance-sheet support and mixed cash-flow trends. Technicals provide some support due to the price trading above major moving averages, but momentum confirmation is limited by a slightly negative MACD. Valuation remains unattractive on an earnings basis given the negative P/E.
Positive Factors
Diverse revenue mix and steady cash flow
A diversified real-estate revenue model—rentals, sales and management fees, plus a mix of long‑term and short‑term leases—reduces single‑channel exposure and smooths cash flow across property cycles. This durable income mix supports operations and funding through multi‑year downturns.
Manageable leverage
A low debt-to-equity ratio provides financial flexibility during prolonged recovery periods, lowering interest burden and preserving borrowing capacity for development or opportunistic acquisitions. This balance sheet conservatism helps absorb earnings volatility without immediate refinancing pressure.
Positive operating cash flow and cash conversion efficiency
Positive operating cash flow and strong cash conversion versus reported income indicate the business can generate liquidity even when accounting profits lag. Over months, this supports working capital, debt service and selective reinvestment without immediate reliance on new equity or external financing.
Negative Factors
Declining revenue trend
Sustained revenue decline reduces scale economics and increases unit cost pressure in property operations. Over a multi‑month horizon, shrinking top‑line constrains margin recovery and investment capacity, forcing management to slow projects or seek non‑core asset sales to stabilize cash flow.
Ongoing losses and weak margins
Persistent negative net margins and low operating margins signal structural profitability issues, limiting retained earnings and reinvestment. Without sustainable margin improvement, the company may struggle to fund growth initiatives, maintain asset quality, or deliver consistent returns to stakeholders over the coming months.
Negative free cash flow growth
Declining free cash flow growth constrains the firm's ability to finance development, pay down debt, or return capital. Even with positive operating cash flow, negative FCF growth over time increases reliance on external funding for capex or acquisitions, raising execution and refinancing risks.

Wanjia Group Holdings Ltd. (0401) vs. iShares MSCI Hong Kong ETF (EWH)

Wanjia Group Holdings Ltd. Business Overview & Revenue Model

Company DescriptionWanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the People's Republic of China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in Fujian province. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
How the Company Makes MoneyWanjia Group Holdings Ltd. generates revenue primarily through property rental income, sales of developed properties, and management fees associated with its real estate projects. The company's revenue model is supported by a mix of long-term leases and short-term rentals, which provide a steady cash flow. Additionally, the group engages in strategic partnerships within the real estate sector to enhance its development capabilities and expand its market reach. The performance of Wanjia Group is influenced by factors such as property market trends, investment demand, and the overall economic environment in the regions where it operates.

Wanjia Group Holdings Ltd. Financial Statement Overview

Summary
Financials are pressured by declining revenue growth (-5.67%) and negative net profit margin (ongoing losses), with weak EBIT/EBITDA margins. Offsetting factors include moderate leverage (debt-to-equity 0.175) and positive operating cash flow, though free cash flow growth is slightly negative (-3.23%).
Income Statement
45
Neutral
The company has experienced declining revenue growth, with a negative growth rate of -5.67% in the latest period. Gross profit margin remains relatively stable at 31.14%, but net profit margin is negative, indicating ongoing losses. EBIT and EBITDA margins are also low, reflecting operational challenges.
Balance Sheet
55
Neutral
The debt-to-equity ratio is moderate at 0.175, suggesting manageable leverage. However, the company has struggled with profitability, as indicated by negative return on equity in recent years. The equity ratio is not provided, but the balance sheet shows a stable equity base.
Cash Flow
50
Neutral
Operating cash flow is positive, but free cash flow growth is negative at -3.23%. The free cash flow to net income ratio is high, indicating efficient cash generation relative to net income, despite overall financial challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue200.69M161.69M181.09M173.70M154.82M114.09M
Gross Profit62.30M50.35M54.74M56.94M54.23M41.34M
EBITDA-135.00K4.13M-29.02M16.40M-34.64M8.16M
Net Income-10.55M-6.62M-39.98M1.82M-51.00M-4.54M
Balance Sheet
Total Assets106.82M106.82M117.10M173.45M191.82M223.59M
Cash, Cash Equivalents and Short-Term Investments24.08M24.08M18.23M9.88M5.77M25.10M
Total Debt11.72M11.72M15.60M25.17M24.49M29.17M
Total Liabilities38.19M38.19M41.91M53.22M63.72M52.51M
Stockholders Equity66.88M66.88M73.49M118.20M126.18M169.31M
Cash Flow
Free Cash Flow9.92M9.92M5.89M5.47M-4.86M-4.34M
Operating Cash Flow10.65M10.65M9.30M9.38M2.12M7.61M
Investing Cash Flow-697.00K-697.00K674.00K-3.84M-6.93M-11.84M
Financing Cash Flow-3.71M-3.71M-1.04M-802.00K-14.97M4.33M

Wanjia Group Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.09
Price Trends
50DMA
0.12
Positive
100DMA
0.12
Positive
200DMA
0.10
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
65.57
Neutral
STOCH
18.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0401, the sentiment is Positive. The current price of 0.09 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.12, and below the 200-day MA of 0.10, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 65.57 is Neutral, neither overbought nor oversold. The STOCH value of 18.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0401.

Wanjia Group Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$7.54B21.396.77%2.72%29.81%10.40%
69
Neutral
HK$2.37B12.595.07%3.81%0.33%-44.28%
68
Neutral
HK$106.40M10.569.25%1.89%27.91%18.87%
60
Neutral
HK$626.40M12.018.12%8.03%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
HK$72.83M-8.50-11.91%-4.50%75.98%
42
Neutral
HK$816.87M-5.91-465.55%-17.39%-45.76%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0401
Wanjia Group Holdings Ltd.
0.13
0.06
75.68%
HK:0673
China Health Group
0.61
0.41
205.00%
HK:1931
IVD Medical Holding Limited
1.46
-0.37
-20.22%
HK:2192
Medlive Technology Co., Ltd.
10.22
1.95
23.58%
HK:2289
Charmacy Pharmaceutical Co., Ltd. Class H
5.80
-2.91
-33.41%
HK:8372
Grand Brilliance Group Holdings Limited
0.13
0.04
44.57%

Wanjia Group Holdings Ltd. Corporate Events

Wanjia Group Calls 2026 EGM to Approve Capital Expansion and Rights Issue
Jan 20, 2026

Wanjia Group Holdings Ltd. has called an extraordinary general meeting (EGM) for 10 February 2026 in Hong Kong, where shareholders will vote on key capital measures. The board is seeking approval to double the company’s authorised share capital to HK$100 million and to conduct a rights issue of up to 560.2 million new shares at HK$0.08 per share on a one-for-one basis for qualifying shareholders, a move aimed at expanding the company’s capacity to raise equity and potentially strengthening its balance sheet, though it will also dilute existing holdings for those who do not subscribe.

The most recent analyst rating on (HK:0401) stock is a Hold with a HK$0.10 price target. To see the full list of analyst forecasts on Wanjia Group Holdings Ltd. stock, see the HK:0401 Stock Forecast page.

Wanjia Group to Double Authorised Share Capital and Launch HK$40–47 Million Rights Issue
Dec 30, 2025

Wanjia Group Holdings Limited plans to double its authorised share capital from HK$50 million to HK$100 million by increasing the number of authorised shares from 1 billion to 2 billion, subject to shareholder approval at an extraordinary general meeting. Conditional on this increase and independent shareholders’ approval, the company will launch a rights issue of one new share for every existing share held at a subscription price of HK$0.08 per rights share, aiming to raise gross proceeds of approximately HK$44.82 million to HK$51.28 million and net proceeds of around HK$40.82 million to HK$47.28 million. The offer will be available only to qualifying shareholders, with compensatory placing arrangements in place, and is intended to strengthen the company’s capital base and provide funding flexibility, which may have implications for existing shareholders through equity dilution balanced against improved liquidity and funding capacity.

The most recent analyst rating on (HK:0401) stock is a Hold with a HK$0.14 price target. To see the full list of analyst forecasts on Wanjia Group Holdings Ltd. stock, see the HK:0401 Stock Forecast page.

Wanjia Group Holdings Reports Revenue Growth but Faces Operational Loss
Nov 19, 2025

Wanjia Group Holdings Ltd. reported a slight increase in revenue for the six months ended September 30, 2025, driven by growth in its Hemodialysis Business. However, the company experienced a loss of HK$0.712 million compared to a profit in the previous year, with no interim dividend declared, indicating financial challenges despite revenue growth.

Wanjia Group Holdings to Review Interim Results and Dividend
Nov 3, 2025

Wanjia Group Holdings Limited has announced that its Board of Directors will hold a meeting on November 19, 2025, to discuss several key issues. The meeting will focus on approving the unaudited interim results for the six months ending September 30, 2025, considering the payment of an interim dividend, and potentially closing the register of members. This meeting is significant as it will determine the financial direction of the company and could impact shareholder returns and market perception.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 31, 2026